Justia Iowa Supreme Court Opinion SummariesArticles Posted in Products Liability
Book v. Voma Tire Corp.
Jim Book, the owner of an auto repair shop in Iowa, bought from an Iowa retailer four Treadstone tires manufactured in China by Doublestar Dongfeng Tyre Company, Ltd. Jim’s son, Dylan Book, was airing up one of the tires when it exploded, causing severe and permanent injuries. Dylan, through his mother, filed a products-liability action in Iowa seeking recovery from Doublestar and Voma Tire Corporation, a national tire distributor that sold several of Doublestar’s tires. Doublestar moved to dismiss for lack of personal jurisdiction. The district court granted the motion. The Supreme Court reversed, holding that the Federal Constitution permits the exercise of personal jurisdiction over a high-volume, foreign manufacturer, such as Doublestar, whose allegedly dangerous product purchased in Iowa injured a resident here. View "Book v. Voma Tire Corp." on Justia Law
Huck v. Wyeth, Inc.
Plaintiff developed a neurological disorder from her prolonged use of metoclopramide, sold under the brand name Reglan and as a competing generic formulation. Plaintiff admitted she ingested only generic metoclopramide but sued both the manufacturer of the generic drug and the manufacturers of the branded formulation. The district court dismissed all of Plaintiff’s claims, ruling (1) Plaintiff’s claims against the generic manufacturer were preempted by federal law that requires conformity with the brand manufacturers’ warning labels approved by the Food and Drug Administration (FDA); and (2) Plaintiff’s claims against the brand manufacturers required proof that the brand defendants manufactured or supplied the product that caused Plaintiff’s injury. The Supreme Court affirmed summary judgment for the brand manufacturers and reversed in part summary judgment for the generic manufacturer, holding (1) Plaintiff’s state common law tort claims against the generic manufacturer based on inadequate warnings were not preempted to the extent that the generic manufacturer failed to adopt warning language approved by the FDA for Reglan; and (2) the brand manufacturers are not liable for injuries to those who used only the competing generic formulation. View "Huck v. Wyeth, Inc." on Justia Law
Posted in: Products Liability